Harada et al. produced a rat model of NMO by injecting NMO-IgG into the spinal cord and then investigated if the blockage of RGMa could offer a beneficial effect in the treatment of the NMO-like disease [12]. The gene discussed is RGMA; the disease is neuromyelitis optica.